SEI Investments’s American Renal Associates Holdings, Inc ARA Stock Holding History

SEI Investments’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,085	Closed	-$67K	–	3025
2018 Q4	$67K	Hold	3,085	–	–	﹤0.01%	2279
2018 Q3	$67K	Buy	+3,085	New	+$58.4K	﹤0.01%	2166

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's ARA Position: Q1 2019 in Review

SEI Investments sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2019, closing a stake of 3,085 shares — an estimated $67K sold.

SEI Investments first reported a position in ARA in Q3 2018 and held it in 2 quarters. The position peaked at $67K in Q4 2018. 68 funds tracked by Wall St. Rank hold ARA as of Q1 2019.

SEI Investments reported no remaining American Renal Associates Holdings, Inc position as of Q1 2019 after selling out during the quarter.
SEI Investments sold 3,085 American Renal Associates Holdings, Inc shares in Q1 2019, an estimated $67K.
SEI Investments first reported a position in American Renal Associates Holdings, Inc in Q3 2018 and held it in 2 quarters.
SEI Investments's American Renal Associates Holdings, Inc position peaked at $67K in Q4 2018.
68 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2019.

Based on SEI Investments's 13F filing for Q1 2019, filed 15 May 2019.